Navigation Links
Al Gore, Tom Stoppard and Amos Oz Are 2008 Dan David Prize winners
Date:2/26/2008

The Dan David Prize, which annually awards three prizes of $1 million each for outstanding achievement, announced the names of its 2008 laureates on February 12. The laureates, who donate 10% of their prize money towards 20 Tel Aviv University doctoral and postdoctoral scholarships, will be honored at a ceremony on May 19, 2008, at Tel Aviv University in the presence of the President of the State of Israel, Mr. Shimon Peres.

Accepting the award, Vice President Gore noted that he would contribute all of his prize money to continuing environmental efforts around the globe. I am happy and pleased to announce that my wife Tipper and I will be donating not only 10 per cent but 100 per cent of all of the Dan David Award to those involved in non-profit activity arousing public opinion in the U.S. and worldwide to solve the climate crises, he said. This entire award will help bring millions of people to a new realization of why we must urgently solve the greatest challenge confronting us today: the climate challenge.

Prize is the Brainchild of International Businessman and Philanthropist

The Dan David Prize is named after international businessman and philanthropist Dan David. It is headquartered at Tel Aviv University, whose President, Prof. Zvi Galil, serves as Chairman of its Board. The Dan David Foundation provides all of the funds for the prize; the board selects the annual laureates.

The Dan David Prize is unique in choosing to recognize fields of human endeavor that change from year to year, permitting the vision of the award to remain responsive to the times.

Artists and Scientists Also Recognized

The 2008 laureates, who are selected in the Past, Present and Future Time Dimensions, are:

Past Sharing the prize in the field of "Creative Rendering of the Past Literature, Theater, Film":

  • Amos Oz (Arad, Israel) for portraying historical events while emphasizing the individual, a
    '/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. GO3 Launches Line of Health-Focused Products with Partner David Beckham
2. MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit
3. Stem Cell Experts and New York Lt. Gov. David Paterson to Participate in 3rd Annual Stem Cell Summit as Keynote Speakers
4. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
5. SAP Names David Corbett as Vice President of U.S. Healthcare Practice
6. LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO
7. Pacira Pharmaceuticals Names David M. Stack CEO and President
8. Radius Ventures Announces Promotion of Dr. David Stoffel to Partner
9. David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
10. Tree named in honor of Virginia Tech chemist David G.I. Kingston
11. Leading Authority on Health Benefits, David Hom, Joins Board of Directors of Healthcare Technology Innovator, NavigatorMD, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Internet use may cut retirees' depression 2
... , ... brings seamless source control management (SCM) to applications and databases. Rational Team Concert customers ... changes resulting in entire projects being deployed in a process-controlled, audited and compliant fashion. ... ...
... ... college, by entering the B’nai B’rith International Diverse Minds Youth Writing Challenge. The teens ... diversity. The winners take home $5,000 college scholarships and will see their books professionally ... (PRWEB) ...
... ... the summer of 2008. At that time, the thought of using cellular technology ... terms of the paper processes that were in place at the time. Now ... and the thought of going back to paper does not even exist. ...
... an editorial about the Reduction by Dutasteride of Prostate Cancer ... Roobol was published in the online version of European ... Urology (EAU). The long-expected final report of the ... New England Journal of Medicine [1] together with a ...
... Do some currently available lubricants used for anal sex ... , The answer is: we don,t know. , ... Microbicide Advocates), brand new research from the Microbicide Trials ... this critical question. , Today at the 2010 ...
... reputable and frequently updated websites and not see online research ... paper in the May issue of the Journal of ... a team from the University of Florida, USA, found that ... get answers to health-related questions, but only 28 to 41 ...
Cached Medicine News:Health News:dbMaestro Achieves “Ready For IBM Rational Software” Validation For Rational Team Concert Integration 2Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2Health News:Caldwell Hospice Upgrades to Latest Version of CellTrak 2Health News:European Urology: Editorial about REDUCE trial underlines value of dutasteride 2Health News:GATOR approach can help surfers to evaluate Web-based health information 2Health News:GATOR approach can help surfers to evaluate Web-based health information 3
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... BRISBANE, Calif., Oct. 27, 2011 InterMune, Inc. (NASDAQ: ... third quarter 2011 financial results at the close of the ... call and webcast will be hosted by InterMune at 4:30 ... and others may participate in the conference call by dialing ...
... 2011 Total quarterly revenues of ... grow 17 Percent, reflecting strong performance of OPANA® ER, Voltaren® Gel ... of $0.34 versus $0.46 for prior year ... from 2010 Company reaffirms 2011 guidance ...
Cached Medicine Technology:InterMune to Release Third Quarter Financial Results on November 3 2Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 2Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 3Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 4Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 5Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 6Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 7Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 8Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 9Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 10Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 11Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 12Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 13Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 14Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 15Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 16Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 17
Atkinson needles have a single bevel with a 22 angle point. Injecting anesthetic agents into the muscle cone. 0.60mm x 38.0mm (23 G x 1 1/2 in)...
Blunt, round tip facilitates easier separation of the nucleus. 45 6.0mm from tip, Blunt, Angled, 6.0mm from tip, 1.5mm from end...
... drape has two perforations which ... to various single or bilateral ... Refractive drape has two perforations ... adapts to various single or ...
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
Medicine Products: